Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2018)
9 slides from Coloplast A/s Class B's investor day presentation, 2018
Slide 1: Chronic Care United Kingdom update
Chronic Care United Kingdom update Coloplast Capital Markets Day 2018 Annemarie van Neck, Vice President, Country Manager UK & Ireland
Slide 2: The UK is Coloplast's largest subsidiary, operating a direct model in a growing yet challenged market
The UK is Coloplast’s largest subsidiary, operating a direct model in a growing yet challenged market UK by Channel UK by Business Area UK Chronic Care organic revenue growth vs. market growth Revenue DKKm, FY 16/17 Revenue DKKm, FY 16/17 FY 16/17 Charter (Direct) Ostomy Care Chronic Care Charter Tr
Slide 3: Charter is performing well and offers services well beyond basic home delivery
Charter is performing well and offers services well beyond basic home delivery Charter revenues in GBPm Charter is now leading the industry in order-to-delivery time… Order Prescription Home taking Collection Delivery … and has been steadily broadening its services 13/14 14/15 15/16 16/17 Digital We
Slide 4: The UK has set out an ambitious plan to accelerate growth over the coming years
The UK has set out an ambitious plan to accelerate growth over the coming years Superior and clinically differentiated products 1 • Offering the broadest product portfolio on the market • Key additions to the portfolio (SenSura Mio Convex and Concave, SenSura Mio Hospital Assortment, and Speedicath
Slide 5: UK has successfully launched key innovations, accelerating growth across Chronic Care
1 SUPERIOR AND CLINICALLY DIFFERENTIATED PRODUCTS UK has successfully launched key innovations, accelerating growth across Chronic Care SenSura® Mio Convex & Concave Brava® accessories SpeediCath® Flex The completed SenSura® Mio Portfolio Brava® accessories is a key contributor to The successful int
Slide 6: We have redefined the UK Direct distribution model for the benefit of consumers, HCPs and NHS
2 UNIQUE CONSUMER RELATIONSHIP We have redefined the UK Direct distribution model for the benefit of consumers, HCPs and NHS We are integrating Distribution and Coloplast Care into one …so that key stakeholders will experience a significant Direct model… positive impact in their interactions with Ch
Slide 7: We are increasing our reach into the community by partnering up closely with local payers
2 UNIQUE CONSUMER RELATIONSHIP We are increasing our reach into the community by partnering up closely with local payers Population Building insights into regional Chronic Care Insight populations Cost Control Optimizing routines and usage Sustainable programs of Coloplast Care, through hands-on nur
Slide 8: We are upscaling our organisation and creating a cross-functional culture of exceeding customer expectations
3 NEXT LEVEL COMMERCIAL EXECUTION We are upscaling our organisation and creating a cross- functional culture of exceeding customer expectations Exceeding customer expectations will be core to all Cross-functional collaboration is key to deliver on our operations, both customer facing and in support
Slide 9: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /